REPL:NASDAQ, Replimune Group, Inc.

REPL stock overview

Replimune Group, Inc. (REPL:NASDAQ) closed at $11.99 on October 22, 2026, up 2.30% on the day. The stock trades 26.6% below its 52-week high of $16.33 and 699.3% above its 52-week low of $1.50. Over the past year, it gained 42.4%. Replimune Group, Inc. is part of the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)).

Key figures

Price
$11.99
Day change
+2.30%
Volume
1,760,567
Average volume
3,931,412
Market cap
1B+
52-week range
$1.50 – $16.33
50-day average
$13.60
200-day average
$9.10

Price action over the past year

In 252 trading sessions since October 22, 2025, REPL closed higher on 115 days (46%). Its best day was July 31, 2026 (+107.02%) and its worst was April 13, 2026 (-64.29%). The stock moved 10% or more in a single session 27 times. It opened at least 5% above the previous day's high 3 times.

Recent signals

REPL news

About Replimune Group, Inc.

Replimune Group Inc is a clinical-stage biotechnology company. Its use proprietary Immulytic platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The company's pipeline products include RP1, RP2, and RP3.

Similar stocks

Find more stocks like REPL with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.